Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Depreciation and Depletion (2020 - 2022)

Caribou Biosciences (CRBU) has disclosed Depreciation and Depletion for 3 consecutive years, with $400000.0 as the latest value for Q2 2022.

  • On a quarterly basis, Depreciation and Depletion rose 100.0% to $400000.0 in Q2 2022 year-over-year; TTM through Jun 2022 was $301000.0, a 62.38% decrease, with the full-year FY2021 number at $1000.0, down 99.89% from a year prior.
  • Depreciation and Depletion was $400000.0 for Q2 2022 at Caribou Biosciences, up from $300000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $400000.0 in Q2 2022 to a low of -$699000.0 in Q4 2021.
  • A 3-year average of $137625.0 and a median of $200000.0 in 2020 define the central range for Depreciation and Depletion.
  • Peak YoY movement for Depreciation and Depletion: crashed 449.5% in 2021, then skyrocketed 100.0% in 2022.
  • Caribou Biosciences' Depreciation and Depletion stood at $200000.0 in 2020, then plummeted by 449.5% to -$699000.0 in 2021, then skyrocketed by 157.22% to $400000.0 in 2022.
  • Per Business Quant, the three most recent readings for CRBU's Depreciation and Depletion are $400000.0 (Q2 2022), $300000.0 (Q1 2022), and -$699000.0 (Q4 2021).